3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
9
Recruiting
8
Completed
4
Terminated
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
13
Endometrial Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms
4
Neoplasms
3
Uterine Neoplasms
2
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Recurrence
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Laryngeal Neoplasms
1
Kenny-Caffey syndrome, Type 1
1
Hyperglycemia
1
High Grade Serous Ovarian Cancer
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Fallopian Tube Neoplasms
1
Interventions
Paclitaxel
16
Carboplatin
15
Bevacizumab
7
Hyperthermic Intraperitoneal Chemotherapy
5
Cisplatin
4
Taxes
3
Gemcitabine
3
Cytoreduction Surgical Procedures
3
Chemotherapy, Adjuvant
3
oregovomab
2
niraparib
2
fluzoparib
2
Topotecan
2
ST 1481
2
Neoadjuvant Therapy
2
Methods
2
Immunohistochemistry
2
Ifosfamide
2
Gene Expression Profiling
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Amplified Fragment Length Polymorphism Analysis
2
rucaparib
1
pembrolizumab
1
paclitaxel poliglumex
1
olaparib
1
navicixizumab
1
mirvetuximab soravtansine
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Fallopian Tube Neoplasms
×
olaparib
×
Clear all
NCT02489006
2024-01-17
NEO
University Health Network, Toronto
Phase 2
Unknown
71 enrolled